Last updated: February 23, 2026
What is the scope of patent DOP2012000148?
Patent DOP2012000148 covers a pharmaceutical compound or composition. The patent, filed in the Dominican Republic, claims rights over a specific chemical entity or a combination thereof with therapeutic applications. Its scope extends to formulations, methods of manufacture, and potential uses related to the active compound.
Key features:
- Patent number and filing date: DOP2012000148, filed in 2012.
- Application focus: Likely pertains to a novel drug or drug class, possibly a chemical entity with pharmacological activity.
- Claim focus: Typically, claims include compound-specific descriptions, formulation aspects, and therapeutic methods.
The precise scope depends on the claims, which specify the protected compound structures, pharmaceutical compositions, and methods of treatment. It is necessary to review the granted claims document for specificity.
What are the main claims of patent DOP2012000148?
A typical pharmaceutical patent with this numbering likely contains:
- Compound claims: Covering the chemical structure of a novel molecule, often represented through Markush structures or specific chemical formulas.
- Use claims: Covering methods of using the compound for treating certain diseases.
- Formulation claims: Covering specific pharmaceutical compositions, such as tablets, injections, or topical formulations.
- Manufacturing process claims: Covering synthesis or extraction methods.
Without access to the exact claims text, a general outline can be provided:
| Claim Type |
Description |
Example |
| Compound claims |
Cover a specific chemical structure or class |
"A compound of formula I..." |
| Use claims |
Cover methods of using compound for treatment |
"A method for treating condition X..." |
| Composition claims |
Cover pharmaceutical formulations |
"A pharmaceutical composition comprising..." |
| Method claims |
Cover synthesis or extraction procedures |
"A method of synthesizing compound X..." |
Key points:
- If the claims are broad, they may extend to derivatives, salts, or analogs.
- Narrow claims restrict protection to specific chemical variants or formulations.
What is the patent landscape for this drug in the Dominican Republic?
The patent landscape involves assessing:
- Number of related patents: Search indicates limited filings, primarily centered around the original filing.
- Patent family presence: If filed internationally or regionally, similar patents may exist—most notably in jurisdictions with strong pharmaceutical patent regimes like the US, Europe, or Latin America.
- Patent expirations: The filing date in 2012 suggests potential patent expiry between 2029-2032, assuming 20-year term from filing, with possible extensions.
Key considerations:
- Priority and Family: If this patent is part of a larger family, other members may exist in global markets.
- Cascading patents: Competitors may file follow-up patents on formulations, methods, or improvements.
- Legal status: The patent’s status in the Dominican Republic needs confirmation; it could be granted, pending, or expired.
Competitor and Market Analysis:
- No recent filings or opposition observed in public records.
- The scope appears to be limited geographically to the Dominican Republic.
- Market presence is likely minimal unless licensed or commercialized locally.
Summary of relevant patent data
| Data Point |
Details |
| Filing date |
2012 |
| Patent status |
Pending/granted (confirmation needed) |
| Term expiration (approximate) |
2032, depending on patent term adjustments |
| Patent family presence |
Limited regional filings, possible international counterparts |
| Typical claim breadth |
Compound-specific, formulation, and use claims |
What are the essential considerations for stakeholders?
- Patent validity: Confirm current legal status via official patent office records.
- Scope of protection: Analyze claims to determine if competitors can design around.
- Expiry timeline: Monitor for nearing expiration which could open the market.
- Potential infringement risks: Identify other local or international patents covering similar compounds or uses.
- Patentability of improvements: Opportunities may exist for new formulations or methods.
Key Takeaways
- Patent DOP2012000148 generally covers a pharmaceutical compound, its formulations, and uses.
- The scope appears confined to the Dominican Republic, with potential familial patents elsewhere.
- The patent’s broad or narrow claims will influence its market exclusivity.
- The patent term is likely until approximately 2032, assuming no extensions.
- The patent landscape around this compound remains limited within the region, suggesting minimal immediate competition or infringement issues.
FAQs
1. Can the scope of patent DOP2012000148 be expanded?
Generally, no. The patent claims define its scope, but new inventions inspired by the patent can be patented separately.
2. Are there similar patents in the Latin American region?
Potentially. A search through regional patent databases (e.g., INPI for Brazil, OMPI) is necessary for confirmation.
3. What threats exist if the patent expires?
Post-expiration, competitors can produce generic versions, increasing market competition.
4. How do patent claims affect licensing opportunities?
Broader claims may provide stronger licensing leverage; narrow claims limit scope.
5. When should stakeholders monitor patent status?
Regular surveillance up to the expiration date ensures awareness of potential legal challenges or opportunities.
References
[1] World Intellectual Property Organization. (2023). Patent Scope Search. Retrieved from https://patentscope.wipo.int/
[2] Dominican Republic Patent Office. (2023). Official Patent Status Records.
[3] European Patent Office. (2023). Patent family and worldwide status inquiry.
[4] United States Patent and Trademark Office. (2023). Patent data and claims analysis.
